FDA ALENDRONATE APPROVAL

被引：2

作者：

MCCARTHY, M

机构：

来源：

LANCET | 1995年 / 346卷 / 8981期

关键词：

D O I：

10.1016/S0140-6736(95)91706-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1028 / 1028

页数：1

共 50 条

[1] FDA approval
不详
[J]. GERIATRICS, 2001, 56 (11) : 16 - 16
[2] FDA approval
不详
[J]. GERIATRICS, 2001, 56 (09) : 16 - 16
[3] FDA approval
不详
[J]. GERIATRICS, 2001, 56 (03) : 20 - 20
[4] FDA approval for ACTIS
不详
[J]. MODERN PLASTICS, 2000, 77 (09): : 10 - 10
[5] Requirements for FDA Approval
Basu, Sankar
[J]. PROCEEDINGS OF LIGHT-ACTIVATED TISSUE REGENERATION AND THERAPY CONFERENCE, 2008, 12 : 269 - 269
[6] FDA Approval for Vectical
不详
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (05) : 497 - 497
[7] FDA Approval for Golimumab
不详
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
[8] FDA APPROVAL IS NOT A SHIELD
Hess, Glenn
[J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (23) : 12 - 12
[9] FDA Approval: Blinatumomab
Przepiorka, Donna
Ko, Chia-Wen
Deisseroth, Albert
Yancey, Carolyn L.
Candau-Chacon, Reyes
Chiu, Haw-Jyh
Gehrke, Brenda J.
Gomez-Broughton, Candace
Kane, Robert C.
Kirshner, Susan
Mehrotra, Nitin
Ricks, Tiffany K.
Schmiel, Deborah
Song, Pengfei
Zhao, Ping
Zhou, Qing
Farrell, Ann T.
Pazdur, Richard
[J]. CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4035 - 4039
[10] FDA and drug approval
Faich, GA
[J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24